Kidney Carcinoma

general

A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis. The majority are renal cell carcinomas. Kidney carcinomas usually affect middle aged and elderly adults. Hematuria, abdominal pain, and a palpable mass are common symptoms.

88

Centers

232

Active Trials

$2.7B

Cancer Funding

Specific Cancer Types(5)

Top Centers for Kidney Carcinoma(88)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
63.8
2
NCI Comprehensive
Active Research Program
63.8
3
NCI Comprehensive
Active Research Program
63.8
4
NCI Comprehensive
Active Research Program
63.8
563.8
6
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
63.8
7
NCI Comprehensive
Active Research Program
63.8
8
NCI Comprehensive
Active Research Program
63.8
9
NCI Comprehensive
Active Research Program
63.8
10
NCI Comprehensive
Active Research Program
63.8
11
NCI Clinical
Active Research Program
63.8
12
NCI Comprehensive
Active Research Program
63.8
13
Active Research Program
63.8
14
NCI Comprehensive
Active Research Program
63.8
15
NCI Clinical
Active Research Program
63.8
16
NCI Comprehensive
Active Research Program
63.8
17
Active Research Program
63.8
18
NCI Comprehensive
Active Research Program
63.8
19
Active Research Program
63.8
2063.8
21
Active Research Program
63.8
22
Active Research Program
63.8
23
Active Research Program
63.8
24
Active Research Program
63.8
25
Active Research Program
63.8
26
Active Research Program
63.8
27
Active Research Program
63.8
28
Active Research Program
63.8
29
Active Research Program
63.8
30
Active Research Program
63.8
31
Active Research Program
63.8
32
Active Research Program
63.8
33
NCI Comprehensive
Active Research Program
41.3
34
NCI Comprehensive
Active Research Program
41.3
35
NCI Comprehensive
Active Research Program
41.3
36
NCI Comprehensive
Active Research Program
41.3
37
NCI Comprehensive
Active Research Program
41.3
38
NCI Comprehensive
Active Research Program
41.3
39
NCI Comprehensive
Active Research Program
41.3
40
NCI Comprehensive
Active Research Program
41.3
41
NCI Comprehensive
Active Research Program
41.3
42
NCI Comprehensive
Active Research Program
41.3
43
NCI Comprehensive
Active Research Program
41.3
44
NCI Comprehensive
Active Research Program
41.3
45
NCI Comprehensive
Active Research Program
41.3
46
NCI Comprehensive
Active Research Program
41.3
47
NCI Comprehensive
Active Research Program
41.3
48
NCI Comprehensive
Active Research Program
41.3
49
NCI Comprehensive
Active Research Program
41.3
50
NCI Comprehensive
Active Research Program
41.3
51
NCI Comprehensive
Active Research Program
41.3
52
NCI Comprehensive
Active Research Program
41.3
53
NCI Clinical
Active Research Program
41.3
54
NCI Comprehensive
Active Research Program
41.3
55
NCI Comprehensive
Active Research Program
41.3
56
NCI Comprehensive
Active Research Program
41.3
57
NCI Comprehensive
Active Research Program
41.3
58
Active Research Program
41.3
59
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
41.3
60
NCI Comprehensive
Active Research Program
41.3
61
Active Research Program
41.3
62
NCI Comprehensive
Active Research Program
41.3
63
NCI Comprehensive
Active Research Program
41.3
64
NCI Comprehensive
Active Research Program
41.3
65
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
41.3
66
NCI Clinical
Active Research Program
41.3
67
Active Research Program
41.3
68
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
41.3
69
NCI Comprehensive
Active Research Program
41.3
70
NCI Basic_laboratory
Active Research Program
41.3
71
Active Research Program
41.3
72
Active Research Program
41.3
73
Active Research Program
41.3
7441.3
75
Active Research Program
41.3
76
Active Research Program
41.3
77
Active Research Program
41.3
78
79
NCI Comprehensive
80
81
NCI Comprehensive
82
83
84
NCI Comprehensive
85
86
87
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
88

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →